- Home
- BBIO vs AMKR Comparison
BBIO vs AMKR Comparison
Compare BBIO & AMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- AMKR
- Stock Information
- Founded
- BBIO 2015
- AMKR 1968
- Country
- BBIO United States
- AMKR United States
- Employees
- BBIO N/A
- AMKR N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- AMKR Semiconductors
- Sector
- BBIO Health Care
- AMKR Technology
- Exchange
- BBIO Nasdaq
- AMKR Nasdaq
- Market Cap
- BBIO 6.7B
- AMKR 6.1B
- IPO Year
- BBIO 2019
- AMKR 1998
- Fundamental
- Price
- BBIO $34.25
- AMKR $18.02
- Analyst Decision
- BBIO Strong Buy
- AMKR Buy
- Analyst Count
- BBIO 12
- AMKR 7
- Target Price
- BBIO $57.09
- AMKR $26.67
- AVG Volume (30 Days)
- BBIO 2.9M
- AMKR 1.8M
- Earning Date
- BBIO 04-29-2025
- AMKR 04-28-2025
- Dividend Yield
- BBIO N/A
- AMKR 4.06%
- EPS Growth
- BBIO N/A
- AMKR N/A
- EPS
- BBIO N/A
- AMKR 1.28
- Revenue
- BBIO $127,415,000.00
- AMKR $6,273,756,000.00
- Revenue This Year
- BBIO $89.10
- AMKR $1.79
- Revenue Next Year
- BBIO $57.07
- AMKR $6.24
- P/E Ratio
- BBIO N/A
- AMKR $14.08
- Revenue Growth
- BBIO N/A
- AMKR N/A
- 52 Week Low
- BBIO $21.62
- AMKR $14.03
- 52 Week High
- BBIO $39.54
- AMKR $44.86
- Technical
- Relative Strength Index (RSI)
- BBIO 50.58
- AMKR 45.84
- Support Level
- BBIO $31.77
- AMKR $17.97
- Resistance Level
- BBIO $33.93
- AMKR $18.94
- Average True Range (ATR)
- BBIO 1.28
- AMKR 0.51
- MACD
- BBIO -0.09
- AMKR -0.13
- Stochastic Oscillator
- BBIO 57.14
- AMKR 9.24
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About AMKR Amkor Technology Inc.
Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.